MAGnesium Effect With ANtiosteoporotic Drugs

Conditions

• Osteoporosis, Postmenopausal

Interventions

• OTHER: Follow-up of patients with postmenopausal osteoporosis, with or without fractures, requiring initiation of injectable bisphosphonate therapy as part of their usual care
• DRUG: Follow-up of patients with postmenopausal osteoporosis, fractured or not, requiring initiation of injectable bisphosphonate therapy as part of care with magnesium supplementation

Sponsor

University Hospital, Clermont-Ferrand